Novel small molecules for animal health
The problem
The animal health industry has historically relied on human pharma as a low-cost source of innovation, leading to a lack of novel animal medicines.
The solution
Bringing the latest advances in drug discovery from human pharma to animal health by enabling ultra-fast, low-cost drug discovery specifically targeted at unmet needs in animal health.
Our engagement
Anterra incubated this company. Subsequent co-investors include Novalis Capital Partners and Finistere Ventures.
Our other companies
Food marketplace helping people eat better effortlessly
Digital procurement platform for farm inputs and services
Innovative materials to extend fresh produce shelf life
Real-time data collection tools for farm machinery
Financial and data services for the fresh produce industry
Next-generation synthetic cellular controls
Drug discovery using machine learning
Genome engineering using CRSPR-Cas9
Novel flavor generation using modified brewer’s yeast
Plant-based enteral nutrition products